Mount Lucas Management LP Sarepta Therapeutics, Inc. Transaction History

Mount Lucas Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$93.7 - $141.53 $15,179 - $22,927	-162 Reduced 8.22%	1,810 $234,000
Q4 2023 Feb 07, 2024	SELL	$67.31 - $124.76 $134 - $249	-2 Reduced 0.1%	1,972 $190,000
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $26,035 - $31,391	-254 Reduced 11.4%	1,974 $239,000
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $237,059 - $350,219	2,228 New	2,228 $255,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Mount Lucas Management LP, based on Form 13F filings with the SEC.

Stay updated on Mount Lucas Management LP with notifications on news.